Nadége Corradini

发表

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers

E. Pasquier, Clara Savary, Laura Broutier, 2023, Cell reports. Medicine.

Treatment at Relapse for Synovial Sarcoma of Children, Adolescents and Young Adults: From the State of Art to Future Clinical Perspectives

R. Alaggio, S. Gatz, P. Gasparini, 2023, Cancer management and research.

Current Management of Desmoid Tumors: A Review.

C. Roland, M. Gounder, E. Baldini, 2024, JAMA oncology.

Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial

K. McHugh, N. Fenwick, G. Barone, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.